Solventum Corp. sells unit to Thermo Fisher

Thermo Fisher Nears Deal for Solventum’s Filtration Unit
Thermo Fisher Scientific is nearing a deal for Solventum’s purification and filtration business, according to people familiar with the matter. A transaction is expected to value the filtration business between $3.
Thermo Fisher strikes $4.1bn deal for Solventum’s purification and filtration unit
GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.
Thermo Fisher to buy Solventum’s purification and filtration unit for $4.1B
Thermo Fisher Scientific agreed to pay about $4.1 billion in cash to acquire Solventum’s purification and filtration business. The technologies, used in the production of biologics and medical devices and for industrial applications,
Thermo Fisher Scientific to Acquire Solventum's Filtration Unit, Confirming WSJ Report
Thermo Fisher Scientific agreed to acquire Solventum's purification and filtration business for $4.1 billion in cash, confirming a report first made in The Wall Street Journal.
Solventum Corp. sells unit to Thermo Fisher for $4.1B
Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo Fisher Scientific for approximately $4.1 billion.
Solventum: An Impressive Sale Of Purification And Filtration
Solventum's $4.1B divestment to Thermo Fisher enhances financial stability, boosts EPS, and strengthens its long-term growth potential. Learn more on SOLV stock here.
Thermo Fisher close to deal to buy Solventum’s filtration unit, WSJ reports
Thermo Fisher (TMO) is close to a deal for Solventum’s (SOLV) purification and filtration business, The Wall Street Journal’s Lauren Thomas
Solventum to Sell Purification Business for $4.1B
M health care spinoff Solventum says it will sell the business unit to Massachusetts-based Thermo Fisher Scientific Inc.
Thermo Fisher Beefs Up in Bioprocessing With $4B Acquisition of Solventum Biz Segment
Thermo Fisher Scientific is expanding its life sciences portfolio by acquiring a division of Solventum that provides technologies and products used in the manufacturing of biologic drugs. Under deal terms announced Tuesday,
Thermo Fisher to Buy Solventum Purification, Filtration Business for $4.1 Billion
Thermo Fisher Scientific (TMO) has agreed to acquire Solventum's (SOLV) purification and filtration business for about $4.1 billion in cash, as the medical-device manufacturer looks to expand its bioprocessing portfolio.
Trian ‘commends’ Solventum on Filtration unit sale, sees cost cut opportunities
Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on ...
Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports
Activist investor Nelson Peltz's Trian Fund Management plans to push Solventum for further business separations following the company's $4.1 billion filtration unit sale, the Wall Street Journal ...
Wall Street Journal4d
Thermo Fisher Strikes Deal for Solventum’s Filtration Unit
The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers to explore a sale of its purification and filtration unit.